Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1995
11/02/1995WO1995029148A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/02/1995WO1995028960A1 Group a streptococcal polysaccharide immunogenic compositions and methods
11/02/1995WO1995028949A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995WO1995028947A1 Permeabilizer peptides for increasing blood-ocular barrier permeability
11/02/1995WO1995028943A1 USE OF SPIRAMYCIN FOR TREATING GASTROINTESTINAL DISORDERS CAUSED BY $i(H. PYLORI)
11/02/1995WO1995028935A1 Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
11/02/1995WO1995028927A1 Polymer coated tablet comprising amoxycillin and clavulanate
11/02/1995EP0679718A2 Process for producing alpha-interferon
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679657A2 Nucleosides and oligonucleotides containing 2'-ether groups
11/02/1995EP0679400A1 Oral dosage forms of azithromycin avoiding drugfood interaction
11/02/1995EP0679194A1 Method to predict active growth of bacteria adhered to a surface
11/02/1995EP0679187A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv.
11/02/1995EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/02/1995EP0679153A1 Amino acids and peptides having modified terminals
11/02/1995EP0679083A1 Prevention and treatment of sepsis
11/02/1995EP0679081A1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
11/02/1995EP0491956B1 Reveromycin a, production thereof, and antitumor drug and fungicide
11/02/1995CA2188697A1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188496A1 Polymer coated tablet comprising amoxycillin and clavulanate
11/02/1995CA2188470A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995CA2188395A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995CA2187928A1 Substituted 5,6-dihydro-5-oxo-1,4-dithiino-(2,3-d)-pyridazine-2,3-dicarbonitriles, compositions containing them and their use as antimicrobials
11/02/1995CA2187459A1 Permeabilizer peptides for increasing blood-ocular barrier permeability
10/1995
10/31/1995US5463104 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/31/1995US5463092 Viricides
10/31/1995US5463063 Preparation of thalidomide; inhibitor of tumor necrosis factor
10/31/1995US5463053 Optically active pyridobenzoxazine derivatives
10/31/1995US5463048 Rapamycin amidino carbamates
10/31/1995US5463046 1-β-methyl-2-thiolic carbapenem derivatives
10/31/1995US5462957 Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases
10/31/1995US5462935 Antibiotic
10/31/1995US5462913 Pesticides, insecticides, miticides, herbicides
10/31/1995US5462853 Contacting samples with lectin to form specific binding complexes between the lectin and components of the sample, determining amount of the complexes, and correlating this amount to the amount of the components in the sample
10/31/1995US5462750 Metal, ceramic or polymeric particles coated with sugars or oligonucleotides which adsorb active materials, for drug delivery or medical diagnosis
10/31/1995US5462692 Stable solid acetylperoxyborate compounds
10/28/1995CA2147798A1 Nucleosides and oligonucleotides having 2'-ether groups
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028487A2 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028406A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
10/26/1995WO1995028398A1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine
10/26/1995WO1995028393A1 Benzamide derivative, compositions containing said derivative and use thereof
10/26/1995WO1995028376A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995CA2188316A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2187791A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same
10/25/1995EP0678516A1 Preparation of 2-bromo-5-(2-bromo-2-nitrovinyl)-furan and its use as microcide
10/25/1995EP0678508A1 Indoles as inhibitors of HIV reverse transcriptase
10/25/1995EP0678298A2 Use of 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid as immopotentiatory agent
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/25/1995EP0678095A1 Crystalline penicillin derivative, and its production and use
10/25/1995EP0678035A1 Vaccine preparations
10/25/1995EP0678034A1 Inducing cytotoxic t lymphocyte responses
10/25/1995EP0678030A1 Use of sulphated polysaccharides for preventing sexually transmitted diseases
10/25/1995CN1110580A Anti-virus and antipyretic oral liquid
10/24/1995US5461154 HIV protease inhibitors
10/24/1995US5461152 Carbocyclic nucleosides containing bicycle rings, oligonucleotides therefrom, process for their preparation, their use and intermediates
10/24/1995US5461146 Enzyme inhibitor protecting nerve cells from degeneration
10/24/1995US5461073 Septicemia suppressing substitution fluid preparation
10/24/1995US5461044 Cephalosporin derivatives
10/24/1995US5461043 Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate
10/24/1995US5461029 Method of treating herpes viral infections using HBNF and MK proteins
10/24/1995US5460815 Culturing Crandall Feline Kidney cells infected with Dahlberg strain feline infectious peritonitis virus in serum containing growth medium, transferring it to serum-free growth medium, separating viral precursor immunogens, inactivating live virus
10/24/1995CA1337408C Soluble phosphorylated glucan
10/24/1995CA1337401C Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995WO1995027780A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants
10/19/1995WO1995027736A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995WO1995027733A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995WO1995027731A1 Compound ge3
10/19/1995WO1995027720A1 Novel erythromycin derivatives, method for preparing same and use thereof as drugs
10/19/1995WO1995027704A1 Anti-helicobacter ester and carbamate derivatives of azolones
10/19/1995WO1995027507A1 Immunodeficiency recombinant poxvirus
10/19/1995WO1995027506A1 Catalase-based anti-helicobacter pylori immunising composition
10/19/1995WO1995027504A1 Borrelia burgdorferi bacterin
10/19/1995WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995020658A3 Diagnosis and treatment of infections due to streptococci and enterococci
10/19/1995WO1995019433A3 Anti-hepatitis b poly- and oligonucleotides
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2187360A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995CA2187299A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995CA2187031A1 Immunodeficiency recombinant poxvirus
10/19/1995CA2185552A1 Anti-helicobacter ester and carbamate derivatives of azolones
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995CA2164729A1 Catalase-based anti-helicobacter pylori immunising composition
10/19/1995CA2164618A1 Compound ge3
10/18/1995EP0677532A1 Use of Il-1-antagonists as medicaments for treating diseases with increased Interleukin-6 serum levels
10/18/1995EP0677523A1 3-(substituted)-1-carba(dethia)-3-cephems and cephalosporins and a process for production therefor
10/18/1995EP0677126A1 Antiviral topical pharmaceutical compositions
10/18/1995EP0677114A1 Recombinant swinepox virus
10/18/1995EP0677063A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS
1 ... 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 ... 1798